Trial intelligence / Profile preview

Metformin as adjuvant treatment for acne vulgaris with microbiota assessment

ChiCTR2200058107Phase 4Recruiting

Sponsor
Affiliated Hospital of Southwest Medical University
Start
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of metformin in acne vulgaris (5 arms), sponsored by Affiliated Hospital of Southwest Medical University. Primary endpoints: Severity of acne vulgaris, Gut microbiota and 1 more. Started Jan 2019; status: recruiting.

02

Drugs

metformin
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on ChiCTR2200058107.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200058107.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call